Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT01310166 · COMPLETED
Trial details
- NCT number
- NCT01310166
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-07-01
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.